Merck Explores Purchase of Biotech Seagen
Share this @internewscast.com



Merck & Co. is eyeing a purchase of biotech Seagen according to people familiar with the matter, a move that would beef up the pharmaceutical giant’s cancer-drug portfolio.

Talks have been under way for a while, and a deal isn’t imminent, the people said, cautioning that pulling one off could be tricky given the heightened risk of a regulatory challenge. It is possible the companies could end up striking a marketing agreement instead, some of the people said.

Share this @internewscast.com
You May Also Like

Maybe The Best Prediction Of Auto Sales Comes From Real-Time Data

A new study shows the frequency of dealership destinations by regions, which…

If You’re Struggling to Solve a Problem, You May Be Looking at Things Just 1% Wrong

This article is excerpted from the new book Build for Tomorrow. We…

20 Years After ‘Legally Blonde’ Hollywood Movie Studios Are Continuing Their Recognition Of Self-Published Authors

384593 09: Actress Reese Witherspoon acts in a scene from Metro-Goldwyn Mayer…

Bitcoin miners hodl 27% less BTC after 3 months of major selling

According to a fresh prediction from crypto analysis firm Arcane Research, miners…

Wait, When Did Everyone Start Using Apple Pay?

Patience isn’t the most popular virtue in Silicon Valley, where companies aspire…

Tornado Cash ban could spell disaster for other privacy protocols — Manta co-founder

There are mounting concerns that recent United States government sanctions against Tornado…

H&M Returns to China’s Internet After a 16-Month Disappearance

By Clarence Leong and Liza Lin Aug. 16, 2022 8:40 am ET…

Petrobas September Calls Offer 90.6% Annualized Return Potential

Brazilian integrated energy giant Petroleo Brasileiro SA (PBR), has been a dividend…